Bluejay Diagnostics, Inc. Finance Lease, Liability, to be Paid, Year Two
Bluejay Diagnostics, Inc. (BJDX) had Finance Lease, Liability, to be Paid, Year Two of $4.81 thousand as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo · last filed 2026-03-06
- 2025-12-31: Finance Lease, Liability, to be Paid, Year Two $4.81K.
- 2024-12-31: Finance Lease, Liability, to be Paid, Year Two $4.81K.
- 2023-12-31: Finance Lease, Liability, to be Paid, Year Two $4.81K.
- 2023-09-30: Finance Lease, Liability, to be Paid, Year Two $100.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Two |
|---|---|
| 2025-12-31 | $4.81K 10-K · filed 2026-03-06 |
| 2024-12-31 | $4.81K 10-K · filed 2025-03-31 |
| 2023-12-31 | $4.81K 10-K · filed 2024-03-28 |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |